Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients
Clinical trial NCT00002098 · COMPLETED
Trial details
- NCT number
- NCT00002098
- Sponsor
- AJI Pharma USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.